India-connected/ Global programs / Human-led
Quality approach

Trust is not a badge.
It is a process.

A strong supplier introduction is not enough. Our operating philosophy is to make quality, documentation and technical fit part of the sourcing decision from the beginning.

Program gates

Five gates before "commercially ready."

The exact depth depends on molecule, market and customer requirements. The principle is constant: important claims should be supported by appropriate evidence.

01
Define

Specification, use, scale, target market, documentation need and critical quality expectations.

02
Screen

Capability, equipment, chemistry, experience, market fit, capacity and initial quality-system evidence.

03
Verify

Relevant documents, technical information, inspection history or other evidence required for the program.

04
Evaluate

Samples, analytics, technical review, customer qualification and gap closure before commercial use.

05
Control

Commercial supply expectations, change communication, deviations, continuity and ongoing performance review.

Our rule

Never sell certainty we have not earned.

We would rather say "this still needs verification" than create false confidence. That protects the buyer, the manufacturing partner and Bombay Molecule.

What this means in practice

No unsupported GMP, regulatory or approval claims.
No assumption that one supplier fits every destination market.
No confidential structure sharing before the right NDA and access path.
No substitution of a document checklist for the customer's own qualification responsibilities.
No hiding known gaps just to win a quote.
Confidentiality

Share the minimum first.

A project code, general chemistry class, approximate scale and target market can often be enough to decide whether a discussion is worth continuing.

For sensitive programs

Request a mutual NDA before disclosing proprietary structures or routes.
Use role-based, secure document exchange when a backend is deployed.
Limit partner disclosure to what is necessary for technical evaluation.
Define ownership of customer IP and new development outputs contractually.
Request NDA first
Important clarification

Bombay Molecule supports qualification. It does not replace it.

Final supplier approval, regulatory suitability and product-use decisions remain subject to the customer's own quality, legal and regulatory processes unless a separate written agreement explicitly assigns specific responsibilities.

Quality questions before an RFQ?

Start with the market, molecule class and documentation expectations. We can structure the conversation before sensitive details are shared.